Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$147,506
-$159,383 QoQ
Shares Held
115,240
-44.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#113
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Dec 31, 2022CallValue
$54,450
CallShares
22,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. GERN ranks #226 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in GERN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $147,506 | 115,240 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $306,889 | 205,967 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,079,566 | 1,575,429 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,651,779 | 1,935,606 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $3,035,482 | 2,152,825 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $1,836,326 | 1,154,923 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $5,411,770 | 1,528,749 | Shares | Defined | 2026-03-19 | |
| 2024-09-30 | $5,901,600 | 1,299,912 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $2,565,119 | 604,981 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $1,871,967 | 567,263 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $3,324,484 | 1,575,585 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,316,419 | 1,564,349 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $2,417,633 | 753,157 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,714,269 | 789,986 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,238,995 | 925,205 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $54,450 | 22,500 | Call | Sole | 2026-03-30 | |
| 2022-09-30 | $832,410 | 355,731 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $27,949 | 18,032 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $68,803 | 50,591 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $451,317 | 369,932 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $185,900 | 135,694 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $68,080 | 48,285 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $385,091 | 243,729 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $154,462 | 97,147 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $228,907 | 131,556 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $872 | 400 | Call | Sole | 2020-08-12 | |
| 2020-06-30 | $306,923 | 140,791 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $116,562 | 97,952 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||